Japan’s Nikkei 225 jumps 2.5% as yen weakens

Japan’s Nikkei 225 jumps 2.5% as yen weakens


Pedestrians cross a road in front of the Tokyo Stock Exchange (TSE), operated by Japan Exchange Group Inc. (JPX), in Tokyo, Japan, on Thursday, Oct. 29, 2020.

Kiyoshi Ota | Bloomberg via Getty Images

Japan stocks led Asian markets higher Thursday, after Wall Street inched higher amid rising tensions in the Middle East.

Japan’s Nikkei 225 opened 2.57% higher while the broad-based Topix added 2%.

The yen slid to as weak as 146.54 against the U.S. dollar overnight. On Wednesday, Japan’s new prime minister, Shigeru Ishiba, told reporters economic conditions don’t currently support another rate hike. Ishiba made his comments after meeting with Bank of Japan Governor Kazuo Ueda.

Investors will look ahead to a busy slate of data in Asia. Australia’s seasonally adjusted Judo Bank Composite PMI data came in at 49.6 in September, lower from the 51.7 in August, falling past the 50 neutral mark. The services PMI posted 50.5, down from 52.5 in August.

The Australian Bureau of Statistics is also expected to report the country’s trade data for August. Economists surveyed in a Reuters poll forecast a surplus of 5.5 billion Australian dollars, down from AU$6.01 billion in July.

Other data on tap include Japan’s PMI data for September and August retail sales from Hong Kong.

Markets in mainland China will remain closed until Oct. 8 for a week-long holiday, while South Korea will be shut Thursday for National Foundation Day.

Australia’s S&P/ASX 200 jumped 0.25%.

Hong Kong’s Hang Seng index futures were at 22,438, slightly lower than the HSI’s last close of 22,443.73, coming off a strong session on Wednesday when the index closed over 6% higher after hitting a 22-month high.



Source

Neurocrine expands into metabolic diseases with .9 billion Soleno buyout
World

Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout

Piotr Swiat | Lightrocket | Getty Images Neurocrine Biosciences will acquire rare-disease drugmaker ⁠Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, marking the neuroscience-focused ​drugmaker’s expansion into ​metabolic disorders. The deal ​gives Neurocrine access to Vykat XR, the first drug approved in the U.S. to treat hyperphagia associated with Prader-Willi syndrome, […]

Read More
JPMorgan CEO Jamie Dimon in annual letter cites risks in geopolitics, AI and private markets
World

JPMorgan CEO Jamie Dimon in annual letter cites risks in geopolitics, AI and private markets

Jamie Dimon, Chairman and CEO, JPMorganChase, speaks during the Reagan National Defense Forum at the Ronald Reagan Presidential Library in Simi Valley, California, U.S. December 6, 2025. Jonathan Alcorn | Reuters JPMorgan Chase CEO Jamie Dimon is calling for a broad recommitment to American ideals as his bank navigates geopolitical uncertainty, a teetering economy and […]

Read More
US and Iran receive peace proposal as Trump vows ‘hell’ if Strait stays shut
World

US and Iran receive peace proposal as Trump vows ‘hell’ if Strait stays shut

Smoke rises after explosions struck the northeastern, western, and central areas amid Israeli attacks in Tehran, Iran on April 1, 2026. Tolga Akbaba | Anadolu | Getty Images The United States and Iran received the framework of a plan to end hostilities, but Iran rejected immediately reopening the Strait of Hormuz, after President Donald Trump […]

Read More